BRZE vs TECH · rev $593.4M vs P/E 65, rev $1.22B
Braze Inc (BRZE) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Braze Inc (BRZE) is a software - application company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported BRZE revenue for 2025-01-31 was $593.4M. Net income was -$104.0M. Revenue was up 25.8% from 2024-01-31 to 2025-01-31. BRZE currently screens at market cap $3.27B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
BRZE currently screens at market cap $3.27B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the BRZE and TECH stock pages for the full models.
Not investment advice.